SCHEMBL25460880

SCHEMBL25460880

CNC(=O)C(C)(C)c1cc(O)cc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ HCAR1 Q9BXC0 1/20 0.39
▸ GABRA1 P14867 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.33
▸ LMNA P02545 2/20 0.32
▸ TACR1 P25103 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ MAPT P10636 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ HSD17B1 P14061 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ LTB4R Q15722 1/20 0.30
▸ LTB4R2 Q9NPC1 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ XBP1 P17861 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460811 0.89 SLC6A3 (0.40) CA12CA1CA9SLC6A3LMNA
SCHEMBL25460807 0.84 CNR2 (0.35) SLC6A3TACR1ALDH1A1MAPTLTB4R
SCHEMBL25460884 0.83 MAPT (0.49) TACR1ALDH1A1MAPT
SCHEMBL25460876 0.81 HDAC3 (0.34) SLC6A3TACR1MAPTLTB4RLTB4R2
SCHEMBL25460808 0.80 HCAR1 (0.44) HCAR1SLC6A3TACR1MEN1KMT2A
SCHEMBL25464778 0.80 CNR1 (0.36) CA12CA1CA9HCAR1GAA
SCHEMBL27664162 0.79 HCAR1 (0.39) HCAR1GABRA1GABRB2GAALTB4R
SCHEMBL25460797 0.79 PARP1 (0.39) SLC6A3ALDH1A1
SCHEMBL25460883 0.79 AKR1C3 (0.39) ALDH1A1MAPTGAANPC1RAB9A
SCHEMBL25460768 0.78 PDK1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR CA12 3422/4885CA1 2899/4885CA9 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback